Literature DB >> 15102849

Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.

Ariel Solomon1, Gabriel Rosenblum, Patricia E Gonzales, Jennifer D Leonard, Shahriar Mobashery, Marcos E Milla, Irit Sagi.   

Abstract

The metalloproteinase tumor necrosis factor-alpha-converting enzyme (TACE) is involved in the regulation of several key physiological and pathological processes. Therefore, potent and selective synthetic inhibitors are highly sought for the study of the physiological roles of TACE as well as for therapeutic purposes. Because of the high structural similarities between the active site of TACE and those of other related zinc endopeptidases such as disintegrin (ADAMs) and matrix metalloproteinases (MMPs), the design of such tailor-made inhibitors is not trivial. To obtain new insights into this problem, we have used a selective MMP inhibitor as a probe to examine the structural and kinetic effects occurring at the active site of TACE upon inhibition. Specifically, we used the selective MMP mechanism-based inhibitor SB-3CT to characterize the fine structural and electronic differences between the catalytic zinc ions within the active sites of TACE and MMP-2. We show that SB-3CT directly binds the metal ion of TACE as observed before with MMP-2. However, in contrast to MMP-2, the binding mode of SB-3CT to the catalytic zinc ion of TACE is different in the length of the Zn-S(SB-3CT) bond distance and the total effective charge of the catalytic zinc ion. In addition, SB-3CT inhibits TACE in a non-competitive fashion by inducing significant conformational changes in the structure. For MMP-2, SB-3CT behaved as a competitive inhibitor and no significant conformational changes were observed. An examination of the second shell amino acids surrounding the catalytic zinc ion of these enzymes indicated that the active site of TACE is more polar than that of MMP-2 and of other MMPs. On the basis of these results, we propose that although there is a seemingly high structural similarity between TACE and MMP-2, these enzymes are significantly diverse in the electronic and chemical properties within their active sites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102849     DOI: 10.1074/jbc.M401310200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Role of MMP2 and MMP9 in TRPV4-induced lung injury.

Authors:  Patricia C Villalta; Petra Rocic; Mary I Townsley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-22       Impact factor: 5.464

Review 2.  Application of structural dynamic approaches provide novel insights into the enzymatic mechanism of the tumor necrosis factor-alpha-converting enzyme.

Authors:  Irit Sagi; Marcos E Milla
Journal:  Anal Biochem       Date:  2007-09-26       Impact factor: 3.365

3.  A profiling platform for the identification of selective metalloprotease inhibitors.

Authors:  Christophe Antczak; Constantin Radu; Hakim Djaballah
Journal:  J Biomol Screen       Date:  2008-03-18

4.  Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction.

Authors:  Natthanej Luplertlop; Natthanej Luplerdlop; Dorothée Missé; Dorothy Bray; Virginie Deleuze; Jean-Paul Gonzalez; Vijittra Leardkamolkarn; Hans Yssel; Francisco Veas
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

5.  A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity.

Authors:  Viera Lukacova; Yufen Zhang; Daniel M Kroll; Soumyendu Raha; Dogan Comez; Stefan Balaz
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

6.  Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential.

Authors:  Netta Sela-Passwell; Raghavendra Kikkeri; Orly Dym; Haim Rozenberg; Raanan Margalit; Rina Arad-Yellin; Miriam Eisenstein; Ori Brenner; Tsipi Shoham; Tamar Danon; Abraham Shanzer; Irit Sagi
Journal:  Nat Med       Date:  2011-12-25       Impact factor: 53.440

7.  The regulation of TACE catalytic function by its prodomain.

Authors:  Xiaoou Li; Yuan Yan; Wei Huang; Yuzhen Yang; Hongwei Wang; Liwen Chang
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

8.  DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2.

Authors:  Peng Tao; Jed F Fisher; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Org Lett       Date:  2009-06-18       Impact factor: 6.005

9.  Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.

Authors:  Laura A Maile; Byron E Capps; Emily C Miller; Lee B Allen; Umadevi Veluvolu; Ariel W Aday; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-02-21

10.  Key feature of the catalytic cycle of TNF-alpha converting enzyme involves communication between distal protein sites and the enzyme catalytic core.

Authors:  Ariel Solomon; Barak Akabayov; Anatoly Frenkel; Marcos E Milla; Irit Sagi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.